Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria G. Glezer"'
Autor:
Evgenii I. Astashkin, Maria G. Glezer
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 52, Iss 2, Pp 95-103 (2024)
Varicose vein disease of the lower extremities is an inflammatory disorder with abnormal structure and functional activity of the venous valves, venous walls and cells, as well as with abnormal activity of the infiltrating leukocytes. The abnormally
Externí odkaz:
https://doaj.org/article/84c2cd2bc41b42f4a13e39b37ab48d5e
Autor:
Nadezhda A. Potemkina, Maria G. Glezer, Petr S. Chomakhidze, Pervin A. Zeynalova, Galina D. Petrova, Alena I. Novikova, Artur N. Gasymov, Maria G. Poltavskaya
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 52, Iss 2, Pp 55-65 (2024)
Rationale: Electrocardiography (ECG) is an objective and widely available method for the diagnosis of cardiovascular disorders recommended for identification of abnormalities, including those in patients with malignancies. A few studies have been pub
Externí odkaz:
https://doaj.org/article/d77d008f9af546dc95508769601f949b
Autor:
Nadezhda A. Potemkina, Maria G. Glezer, Pervin A. Zeynalova, Petr S. Chomakhidze, Alena I. Novikova, Galina D. Petrova, Maria G. Poltavskaya
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 51, Iss 5, Pp 259-269 (2023)
Background: High dose chemotherapy (HDCT) preceding autologous hematopoietic stem cell transplantation (autoSCT) can be toxic for cardiovascular system, which can be mediated with the development of endothelial dysfunction. No studies on the assessme
Externí odkaz:
https://doaj.org/article/3a1e7fb3afd74f989330c5b0cf13340b
Autor:
Alexey V. Azarov, Maria G. Glezer, Andrey S. Zhuravlev, Avtandil M. Babunashvili, Sergey P. Semitko, Ionatan R. Rafaeli, Il'ya A. Kovalchuk, Inomali K. Kamolov, Danizat Z. Masaeva, David G. Ioseliani
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 50, Iss 2, Pp 77-93 (2022)
Background: There have been a big number of studies assessing the efficacy of delayed coronary artery stenting (DCAS) in the prevention of no-reflow microvasculature injury compared to the standard immediate coronary artery stenting (ICAS) in ST-segm
Externí odkaz:
https://doaj.org/article/2adb5e06e9204de592f233a5b75ef70e
Autor:
Gregory P. Arutyunov, Yuri M. Lopatin, Aleksandr S. Ametov, Fail T. Ageev, Mikhail B. Antsiferov, Svetlana V. Villevalde, Nadezhda G. Vinogradova, Gagik R. Galstyan, Albert S. Galyavich, Sergey R. Gilyarevskiy, Maria G. Glezer, Igor V. Zhirov, Mikhail V. Ilyin, Anastasiya Iu. Lebedeva, Sergey M. Nedogoda, Vladimir V. Salukhov, Ekaterina I. Tarlovskaya, Sergey N. Tereshchenko, Igor V. Fomin, Iurii Sh. Khalimov, Niaz R. Khasanov, Dmitriy V. Cherkashin, Sergey S. Yakushin
Publikováno v:
Терапевтический архив, Vol 93, Iss 12, Pp 1491-1497 (2021)
At an international online expert meeting held on September 16, 2021, the results of the empagliflozin research program EMPA-REG Outcome, EMPEROR-Reduced and EMPEROR-Preserved were reviewed. We analyzed cardiovascular and renal outcomes during the tr
Externí odkaz:
https://doaj.org/article/cb0d25caa8e542fa8a22693834a280ca
Publikováno v:
Cardiology and Therapy, Vol 9, Iss 2, Pp 395-408 (2020)
Abstract Introduction Trimetazidine (TMZ) is an antianginal agent that acts directly at the myocardial cell level and which is now available in a once-daily (od) formulation. Methods ODA, a 3-month, observational, multicenter study in Russia, assesse
Externí odkaz:
https://doaj.org/article/abe8bd6cbef141cabeb65f737db3a24a
Publikováno v:
Cardiology and Therapy, Vol 8, Iss 1, Pp 69-78 (2019)
Abstract Introduction Trimetazidine (TMZ) has been shown to be efficacious for angina treatment. The TMZ 80-mg formulation allows one-daily (od) dosage, which could improve symptom control and adherence. Methods The 3-month, observational, multicente
Externí odkaz:
https://doaj.org/article/d3c337e2da0b4f67886fcfb1b3261c0a